Steven R. Feldman, MD, PhD, summarizes the latest information on the advances in biosimilar research and development, while providing clinical implications of recent clinical data and ongoing trials involving biosimilars in relation to the data for their reference biological product. The goal of this program is to raise awareness about biosimilars, and discuss recent data, which may provide more trust in the use of biosimilars and ultimately prove beneficial to patients.
This activity was developed for rheumatologists, dermatologists, gastroenterologists, and other health care professionals who have an interest in biosimilars.
|Available Credit:||1.50 AMA PRA Category 1 Credits™.|
|Opens:||June 15, 2017|
|Expires:||June 14, 2018|
Other Health Care Providers